Placeholder Banner

Life Sciences Community Joins Rep. Charlie Dent to Discuss State of the Industry and Positive Impact on Pennsylvania

August 18, 2016

WHAT: Roundtable discussion about the life sciences landscape, including the industry’s economic impact on Pennsylvania, the value of innovation, bioscience education opportunities, NIH funding and research best practices. Rep. Charlie Dent and Hon. Jim Greenwood to deliver remarks

WHO:
• Rep. Charlie Dent (R-PA-15)
• Hon. Jim Greenwood, President & CEO, BIO; former PA Congressman
• Mr. Craig Tucker, Vice President, PA BIO • Dr. Keri Donaldson, Founder, Prescient Medicine
• Dr. Ralf Brandt, CEO & Managing Director, vivoPharm
• Dr. Kent Vrana, Professor & Chair, Penn State Dept. of Pharmacology
• Dr. Mel Billingsley, President & CEO, Life Sciences Greenhouse of Central PA
• Ms. Caitlin Orr, Project Coordinator, Hershey Center for Applied Research
• Mr. Nick Magallanes, Director Federal Government Relations, BIO

WHEN: Tuesday, August 23, 2016, 1:30 to 2:30 p.m. (Eastern Time Zone)

WHERE:
Hershey Center for Applied Research
Room 1103
1214 Research Boulevard
Hummelstown, PA 17036  


https://www.bio.org/sites/default/files/SP_Pennsylvania_0.pdf

 

Discover More
Seed technology companies comply with Mexico’s biosafety regulations, and Mexico should do the same, BIO said today in its response to the panel set up to determine if Mexico’s ban on imports of genetically modified corn violate its commitments…
BIO President & CEO John F. Crowley announced today that BIO would take several important steps to reaffirm the organization’s position with regards to national security and the role that the industry plays as a vital strategic asset: “As a…
Following the conclusion of the WTO 13th Ministerial Conference in Abu Dhabi, John Murphy -- BIO's Chief Policy Officer -- made the following statement: “We are encouraged that WTO Members did not agree to extend an intellectual property…